Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22711,96,0.83 [0.52-1.31],0.417106903039389
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23324,173,1.12 [0.86-1.46],0.4067672159302989
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23098,1131,1.08 [0.97-1.20],0.1765742874623606
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Candidiasis,23348,407,1.13 [0.95-1.34],0.1762311949616095
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22621,2949,1.02 [0.95-1.09],0.6196093082878845
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22836,2413,1.02 [0.94-1.10],0.6899197906074725
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23114,1143,1.04 [0.93-1.16],0.474313248245408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23256,76,1.25 [0.88-1.78],0.2139832510578407
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21808,671,0.99 [0.85-1.15],0.9004139798974365
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,775,1.01 [0.88-1.16],0.9070296550074846
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21123,214,1.12 [0.88-1.43],0.34523679240161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16352,1382,0.98 [0.88-1.09],0.7133651148176221
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20938,315,1.24 [1.04-1.48],0.0166862015464772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23296,1325,1.09 [0.99-1.21],0.0739043956037443
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,23399,458,1.11 [0.94-1.31],0.2167880630816705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22766,799,1.11 [0.97-1.25],0.1190462552255292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23353,738,0.97 [0.84-1.13],0.7128094019794147
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22144,173,1.13 [0.86-1.48],0.3719057967937454
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23457,37,0.48 [0.19-1.23],0.124722459651703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23267,652,1.01 [0.87-1.17],0.91163194602341
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23254,74,0.93 [0.58-1.51],0.7803645523974259
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23372,163,1.05 [0.79-1.40],0.729327343449158
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23358,149,0.99 [0.72-1.36],0.9443049703876868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22250,283,0.96 [0.76-1.22],0.7570345888893999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22192,225,1.08 [0.85-1.38],0.5089915447533635
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22071,100,1.51 [1.19-1.92],0.0008052328394758
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23434,32,0.83 [0.38-1.84],0.6505959306860953
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23390,139,1.07 [0.79-1.45],0.6691392854456251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral warts,23290,39,0.68 [0.31-1.53],0.3544063432562844
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23321,70,1.38 [1.00-1.91],0.0474226949472902
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,23214,200,1.06 [0.82-1.37],0.6730399546068548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23365,57,1.34 [0.92-1.93],0.1229429103046805
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23358,58,1.00 [0.60-1.65],0.9911690283358754
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23204,1028,1.10 [0.99-1.23],0.0785191261764024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of meninges,23433,74,0.87 [0.53-1.44],0.5897334316506939
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,0.96 [0.57-1.63],0.8851951452774287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23426,114,1.27 [0.96-1.69],0.0971418485671358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,1.12 [0.85-1.48],0.4316327613740247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23437,230,1.14 [0.91-1.43],0.2504194668077044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Caecum,23444,212,1.19 [0.95-1.49],0.127819322052349
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23377,56,0.95 [0.55-1.63],0.8437461852252799
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Descending colon,23442,130,0.96 [0.67-1.37],0.8172549775704109
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,23403,237,0.97 [0.75-1.25],0.8050473769853111
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23357,427,1.12 [0.95-1.33],0.1777992860628869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23442,244,1.08 [0.86-1.36],0.5053681628272448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,1.05 [0.75-1.47],0.7719675592919352
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.88 [0.61-1.27],0.4890596741295936
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19070,31,0.64 [0.25-1.62],0.3477605592435115
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19095,56,0.87 [0.49-1.56],0.6469632776230987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23396,123,1.30 [1.00-1.69],0.046417510406926
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",23397,121,1.32 [1.02-1.71],0.0366038215853661
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,1.08 [0.93-1.27],0.3150739850447755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lung cancer and mesothelioma,16845,271,1.00 [0.82-1.23],0.9958523840595928
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lymphoid leukaemia,19072,33,1.16 [0.65-2.08],0.6157359494209294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19191,152,0.98 [0.71-1.34],0.8828940540999656
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19133,94,1.00 [0.67-1.48],0.9825526060352628
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.24 [0.97-1.59],0.0837967586742397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19099,60,1.06 [0.66-1.71],0.801277423213894
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19100,61,1.46 [1.07-2.00],0.0171992169655348
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19088,49,1.29 [0.86-1.94],0.2208121570815711
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,0.90 [0.62-1.32],0.6005391406951056
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19128,89,0.85 [0.53-1.36],0.488551878707153
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19110,71,0.73 [0.41-1.30],0.285897891559921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19073,34,0.55 [0.22-1.41],0.2125449609864303
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19109,70,0.98 [0.61-1.56],0.928220875690461
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,23230,204,1.07 [0.84-1.38],0.5660696532185212
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of trunk,23421,69,0.82 [0.48-1.39],0.4518464133683182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanoma in situ,19066,75,0.40 [0.20-0.79],0.0082449397640479
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19108,69,0.81 [0.47-1.40],0.4516385533378577
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19168,129,1.00 [0.71-1.40],0.9795045479415296
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19240,201,0.99 [0.76-1.28],0.9128170777606662
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19119,80,0.80 [0.48-1.33],0.3924555371930429
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,23264,149,1.18 [0.91-1.54],0.2130406174357156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19827,788,0.99 [0.86-1.13],0.8593764949362404
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19862,823,1.02 [0.89-1.16],0.7782416833276317
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23184,330,1.09 [0.90-1.33],0.3565202141983228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21758,83,1.02 [0.67-1.56],0.9158681206556574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22922,68,0.80 [0.46-1.39],0.4309111735887101
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22589,2521,1.11 [1.04-1.19],0.0032461313480423
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22086,27,0.66 [0.24-1.78],0.4063720482860907
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23115,43,1.07 [0.62-1.87],0.799996079788034
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22956,1281,1.10 [1.00-1.22],0.0507449003202553
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22956,1281,1.10 [1.00-1.22],0.0507449003202553
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21741,66,1.06 [0.68-1.67],0.788435883564685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23107,1048,1.08 [0.96-1.20],0.2006134189193626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23173,101,1.36 [1.03-1.79],0.0293844921148913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22897,43,1.05 [0.60-1.85],0.8527588633732185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22906,52,0.98 [0.57-1.67],0.9305475848144824
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23270,198,1.21 [0.96-1.52],0.1022025655269858
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23362,53,1.23 [0.81-1.88],0.3342460615444815
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23240,168,1.20 [0.93-1.53],0.1580803587875395
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22171,112,1.24 [0.93-1.66],0.1474836451471535
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18899,203,1.26 [1.02-1.56],0.033321818178771
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22241,55,0.79 [0.41-1.54],0.4920962247238398
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22240,54,0.52 [0.23-1.16],0.1113794218952157
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18739,43,1.31 [0.83-2.06],0.2430833394244109
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21525,53,0.82 [0.45-1.51],0.5278859144360135
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21225,210,1.12 [0.89-1.42],0.334524151978849
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23084,405,0.87 [0.70-1.08],0.2161670803489324
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22931,252,0.83 [0.63-1.10],0.2027689825066052
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22737,58,1.10 [0.69-1.75],0.6842396115257179
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23133,1661,0.93 [0.84-1.02],0.1399617796836489
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20803,1624,0.92 [0.83-1.02],0.1251729836785144
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18743,47,1.06 [0.62-1.81],0.8351417102021064
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20854,101,0.94 [0.63-1.41],0.776657111534216
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18940,244,1.19 [0.96-1.47],0.1119761987723875
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18737,41,1.03 [0.57-1.84],0.9285283311211197
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21378,2682,0.97 [0.90-1.05],0.4347618650330874
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18876,180,0.91 [0.66-1.24],0.5356772841469208
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19165,469,1.13 [0.96-1.32],0.1341053216674054
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23375,306,1.12 [0.92-1.37],0.256996729761313
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23212,143,1.29 [1.00-1.65],0.0492822175978596
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18784,88,1.09 [0.74-1.59],0.662988161613305
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18745,49,0.78 [0.40-1.52],0.4564057030564279
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22710,1957,1.02 [0.94-1.11],0.6639339090177148
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18867,171,1.19 [0.93-1.54],0.1740908752805824
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18864,168,1.07 [0.80-1.43],0.6519413819000923
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19153,457,1.12 [0.95-1.32],0.1821576804318162
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18764,68,0.86 [0.50-1.46],0.5709740657773594
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23206,137,1.29 [1.00-1.66],0.0540001202013457
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19220,524,1.13 [0.97-1.31],0.1163391415458288
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19169,473,1.06 [0.89-1.26],0.5023986133409446
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21077,62,1.33 [0.93-1.92],0.1205534385855375
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22707,4011,1.02 [0.96-1.08],0.5738780872190105
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20815,62,0.98 [0.59-1.62],0.9343837757222908
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20830,77,1.28 [0.92-1.78],0.1405599804761291
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23294,1758,0.99 [0.90-1.09],0.826134405646375
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23298,1757,0.99 [0.90-1.09],0.8693772534446813
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20824,71,0.65 [0.35-1.20],0.1689965225113666
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23104,1348,0.98 [0.88-1.09],0.6908704292853339
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19971,1275,1.10 [0.99-1.21],0.0630470755010013
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23448,152,1.02 [0.74-1.40],0.9036315875228298
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22720,41,0.93 [0.49-1.75],0.8110336964682128
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21871,115,1.07 [0.77-1.50],0.6842151723863035
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21924,168,0.75 [0.52-1.09],0.1315174449357191
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18910,214,1.00 [0.77-1.31],0.9721376368688442
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21901,118,1.20 [0.89-1.60],0.2343521744477885
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1448,37,1.00 [0.53-1.90],0.9980227394677924
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1541,149,1.26 [0.94-1.68],0.1231755208028392
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21807,24,0.99 [0.43-2.27],0.9792837585516704
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1432,22,1.55 [0.85-2.81],0.1522947618403051
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23053,1270,0.98 [0.87-1.09],0.6868530425850549
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22964,285,0.93 [0.73-1.19],0.5647075366967987
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21427,412,1.17 [0.99-1.38],0.0701774481436994
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19302,606,1.10 [0.96-1.27],0.1723650307805347
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23371,206,1.02 [0.78-1.33],0.8979344967461197
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22573,45,1.10 [0.64-1.89],0.7205906548764334
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,22158,729,0.95 [0.81-1.10],0.4836861534812439
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22609,81,1.01 [0.65-1.56],0.9683510907896205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22558,30,1.16 [0.62-2.17],0.6316476697663123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22666,138,1.24 [0.95-1.62],0.1196818584101991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15241,1238,1.02 [0.92-1.14],0.6999213980240918
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,AV-block,20580,205,1.02 [0.78-1.33],0.9065484538684206
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23415,260,0.54 [0.38-0.76],0.0003879002029728
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiac arrest,14109,106,0.92 [0.61-1.38],0.6888125456637816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20495,120,1.02 [0.72-1.45],0.8945087710886052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20448,73,0.83 [0.49-1.41],0.4947888096190491
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23454,26,1.18 [0.63-2.22],0.6039297394608056
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,20994,619,1.14 [1.00-1.31],0.0560866871409815
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22681,1261,1.03 [0.92-1.14],0.6315866102134877
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21106,6213,0.97 [0.92-1.02],0.2135564672816475
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22181,219,0.99 [0.76-1.29],0.9277434494616614
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Endocarditis,20420,45,1.06 [0.61-1.84],0.8354396375022843
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23375,706,1.06 [0.92-1.21],0.4504823436544515
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,21636,5222,0.99 [0.94-1.05],0.8368786657494797
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21644,5230,0.99 [0.94-1.05],0.8092571765786163
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23359,34,1.11 [0.60-2.03],0.7395440969016711
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16562,148,1.02 [0.74-1.41],0.8967963605660477
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16479,65,1.13 [0.74-1.74],0.5768014101621716
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,23342,907,0.97 [0.85-1.11],0.6286949219772446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22820,81,0.68 [0.39-1.20],0.1815806661618258
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22855,1426,1.01 [0.91-1.12],0.8220801997189834
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23192,382,1.01 [0.82-1.23],0.9430649298860684
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20637,262,1.22 [1.00-1.49],0.0501954178261507
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23271,517,1.05 [0.89-1.23],0.5906980327631808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21846,417,1.08 [0.90-1.30],0.3845383954694257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23433,76,1.01 [0.65-1.57],0.9785963843744044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23449,209,1.08 [0.84-1.39],0.5422655272428155
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Oesophageal varices,21995,33,1.09 [0.58-2.04],0.791502592888762
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other aneurysm,22578,50,0.79 [0.42-1.52],0.4870637326358742
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,20680,305,0.83 [0.64-1.07],0.1505093269279342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22589,61,1.38 [0.96-1.97],0.0786153700003279
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22701,173,1.36 [1.10-1.69],0.0041425591260814
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20521,146,0.94 [0.67-1.31],0.711198449198712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other disorders of veins,22037,75,1.28 [0.91-1.80],0.1558631244750762
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22003,41,0.74 [0.35-1.56],0.4265204482783323
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22403,32,0.81 [0.36-1.83],0.6121430066115581
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22092,130,0.98 [0.69-1.39],0.9236243933364374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21040,665,1.13 [0.99-1.29],0.0802507276356989
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22472,37,0.89 [0.44-1.78],0.7358934793018566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22968,440,1.06 [0.89-1.27],0.4979092199969906
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22957,278,1.09 [0.88-1.35],0.4399338469292676
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22824,453,0.97 [0.80-1.18],0.7762152426580471
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14251,248,1.00 [0.78-1.27],0.9853183348771491
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22761,243,1.13 [0.90-1.41],0.3048892498333237
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22246,284,0.98 [0.77-1.23],0.8377455266875177
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23056,377,1.02 [0.84-1.24],0.8321375973133466
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23387,491,1.08 [0.91-1.27],0.3768648331381202
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20557,182,0.96 [0.71-1.29],0.7769953337242712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22951,272,1.11 [0.89-1.37],0.3502015662386996
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22501,130,1.05 [0.75-1.46],0.7873666294083324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23183,444,0.96 [0.79-1.17],0.6865811458235018
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23161,484,0.94 [0.78-1.14],0.5450472790427912
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22793,61,0.88 [0.51-1.53],0.6525636375272572
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22564,36,0.85 [0.40-1.77],0.6570830053729193
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22987,177,1.38 [1.12-1.70],0.0020751384076355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22925,171,0.93 [0.68-1.28],0.6698861735858892
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,22335,373,1.04 [0.86-1.26],0.6539842575831364
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22538,82,0.71 [0.41-1.23],0.2244113273498824
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23273,599,0.99 [0.84-1.16],0.9158879833126446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23420,192,0.95 [0.71-1.27],0.7455574562039744
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20862,1575,0.98 [0.89-1.08],0.6629436640975784
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,22951,3664,0.99 [0.93-1.05],0.7054203478774359
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23394,224,0.89 [0.67-1.18],0.4257070516466636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20964,1677,0.92 [0.83-1.02],0.095722384013685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19364,77,1.08 [0.72-1.62],0.7124360598582956
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,23110,1015,1.02 [0.90-1.15],0.7589423364077723
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20461,1174,1.00 [0.89-1.11],0.941964810051604
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Vascular dementia,23043,91,0.78 [0.48-1.27],0.3228086129644025
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Alzheimer disease,23455,313,0.88 [0.69-1.12],0.296648890004578
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16087,51,0.67 [0.33-1.36],0.2666426281619626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Bell's palsy,21631,72,0.64 [0.35-1.17],0.1476260094568408
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22097,538,0.91 [0.76-1.08],0.2854682479542257
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral cysts,23111,187,0.93 [0.69-1.25],0.6359448733410704
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23393,229,1.03 [0.80-1.32],0.8433882166050904
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23046,36,1.39 [0.89-2.17],0.1533304236471322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23444,43,0.63 [0.29-1.38],0.2489126694505755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22969,45,0.75 [0.37-1.53],0.4350569484265212
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,22212,236,0.97 [0.75-1.25],0.7885773603587568
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23095,1119,0.97 [0.86-1.09],0.5920369194344648
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23412,300,0.83 [0.64-1.08],0.1590095765201277
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22923,2449,0.92 [0.85-1.00],0.0611307052982138
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Generalized epilepsy,23147,40,1.48 [1.01-2.18],0.0444838909096094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,23346,182,0.99 [0.74-1.32],0.9281785088555374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hydrocephalus,22980,56,0.62 [0.31-1.26],0.1872840164211368
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23438,67,0.89 [0.53-1.49],0.6581483222641928
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21665,106,0.88 [0.59-1.32],0.5345441460519522
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21614,55,1.12 [0.71-1.77],0.6181421819967519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Memory loss,22935,92,0.78 [0.48-1.27],0.3198265311277252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,22409,433,0.91 [0.75-1.11],0.3615627455280931
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23359,393,0.93 [0.76-1.14],0.4803252144750625
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Motor neuron disease,16172,112,1.13 [0.82-1.55],0.4630899260207595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23264,121,1.09 [0.80-1.49],0.5863333236499301
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22743,1184,0.82 [0.72-0.93],0.0027960590955027
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,22071,3143,0.91 [0.85-0.98],0.0140235581417271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23132,122,0.88 [0.60-1.30],0.5252496554559708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21920,361,0.78 [0.61-0.99],0.0440759320013537
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23408,196,1.16 [0.91-1.47],0.2352680195942189
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18981,558,0.93 [0.78-1.11],0.4179452255915012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22981,57,1.06 [0.65-1.73],0.8185163732618479
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23032,108,1.08 [0.76-1.53],0.6731899839511406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23251,139,0.76 [0.51-1.13],0.1769653340615538
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21639,80,0.57 [0.31-1.04],0.0677331309515599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other headache syndromes,22045,69,1.04 [0.66-1.64],0.855833809249292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,23353,429,0.99 [0.82-1.19],0.8996710546668123
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,22312,336,0.78 [0.60-1.01],0.0605453929348416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Parkinson's disease,23433,141,0.78 [0.53-1.16],0.2155970508963239
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22995,71,0.88 [0.53-1.46],0.6178435898419752
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Restless leg syndrome,23454,75,0.88 [0.54-1.45],0.6248457334861031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,272,0.83 [0.63-1.09],0.1869657878327614
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23245,33,0.99 [0.50-1.95],0.9790683607620364
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23445,136,1.12 [0.83-1.50],0.4595534143823536
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21616,57,0.68 [0.35-1.31],0.2465389007792976
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23455,316,0.86 [0.68-1.11],0.2455763933180216
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23004,88,0.76 [0.46-1.26],0.2827191425959414
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22943,93,0.79 [0.49-1.28],0.3339530790979358
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23064,423,1.18 [1.00-1.38],0.0482332467119821
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23331,141,1.20 [0.90-1.59],0.2205024167779889
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22502,51,1.53 [1.10-2.14],0.0125696363594368
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22498,47,0.79 [0.41-1.54],0.4869095728147455
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23344,55,0.85 [0.47-1.54],0.5952122700729436
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23214,148,1.19 [0.91-1.56],0.2119959267457393
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1439,28,1.72 [1.05-2.81],0.0316492288498075
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1727,54,1.27 [0.82-1.99],0.2880582526503519
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22934,84,1.05 [0.70-1.57],0.8119563354187864
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23307,896,1.05 [0.92-1.19],0.4750940358305603
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23093,642,1.10 [0.95-1.27],0.1861196305927033
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22709,258,1.18 [0.95-1.45],0.1287853836628335
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23380,739,1.04 [0.90-1.19],0.6118052571134012
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23443,62,1.31 [0.91-1.90],0.1510458826901083
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23317,676,1.07 [0.93-1.23],0.3556515520475075
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23417,351,1.09 [0.90-1.32],0.3990982195864303
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23376,180,0.85 [0.61-1.19],0.3430350439040225
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22489,38,0.55 [0.22-1.35],0.192706287996575
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22492,41,1.11 [0.62-1.96],0.7279989455046968
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22512,61,1.17 [0.76-1.81],0.4668880368484365
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23381,609,1.00 [0.85-1.17],0.9818533737708072
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22923,151,0.87 [0.61-1.25],0.4558576084924097
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22694,53,0.93 [0.52-1.65],0.796066601927808
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23150,84,1.09 [0.74-1.62],0.6500986678684395
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23342,276,1.09 [0.87-1.35],0.4574805803638581
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22824,183,0.88 [0.64-1.21],0.4213381795233748
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23312,116,0.73 [0.46-1.14],0.1679671709528296
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23169,397,1.06 [0.88-1.28],0.5336134422025001
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22985,135,1.08 [0.79-1.48],0.6234206208450405
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21921,2165,1.00 [0.92-1.09],0.9895647880151586
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23308,242,1.13 [0.90-1.41],0.3016750507634184
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23433,139,1.02 [0.74-1.41],0.9044079480404448
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22785,334,1.15 [0.95-1.38],0.1547448870754368
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23121,55,0.79 [0.42-1.48],0.4640766435328631
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23430,49,1.11 [0.67-1.84],0.6820301900202741
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22532,81,1.41 [1.05-1.91],0.0241520608429297
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22579,128,1.11 [0.82-1.52],0.4955024843493959
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22498,87,0.88 [0.56-1.40],0.5968059753357696
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22695,54,0.77 [0.41-1.45],0.4202589313632443
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22465,54,0.68 [0.35-1.34],0.2636151750889911
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22872,100,0.63 [0.38-1.06],0.082450206699664
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22928,156,1.01 [0.74-1.37],0.9653503899502198
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22562,111,1.38 [1.05-1.80],0.0196565755709578
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22491,80,1.13 [0.78-1.64],0.5139144365165725
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22467,56,0.57 [0.28-1.18],0.1302104226620337
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21539,1783,1.02 [0.93-1.11],0.7381436563483397
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22528,77,1.17 [0.79-1.72],0.4333495572970822
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23225,375,0.97 [0.79-1.19],0.7711186945183526
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22889,39,0.67 [0.30-1.50],0.3272138030928146
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22998,148,0.85 [0.59-1.23],0.3931459048643188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23237,99,1.03 [0.70-1.50],0.8839060283061232
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23415,94,1.13 [0.80-1.61],0.4779290656378316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23351,122,0.98 [0.69-1.39],0.9098868466441428
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23200,62,1.19 [0.79-1.80],0.4103563942481348
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23203,65,0.91 [0.54-1.52],0.7116197236241586
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23364,680,0.96 [0.83-1.12],0.6293114991670445
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23150,466,1.00 [0.84-1.20],0.96940555725887
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22784,100,1.04 [0.71-1.51],0.8513132628891822
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22756,72,0.86 [0.52-1.44],0.5758376324336074
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute pharyngitis,23212,75,0.93 [0.58-1.49],0.7536414024258711
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23343,206,1.05 [0.82-1.36],0.682802500236392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23192,55,0.96 [0.57-1.64],0.887928849274723
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza,22017,108,1.20 [0.88-1.65],0.2557235558068556
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22016,107,1.21 [0.89-1.66],0.2261471539704718
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16685,111,1.05 [0.74-1.48],0.7909016716687455
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic rhinitis,23331,242,0.78 [0.58-1.05],0.1028904456378507
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18210,1792,0.93 [0.84-1.02],0.1376361961984281
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18345,1771,0.93 [0.84-1.02],0.1337044153235859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23107,114,1.11 [0.80-1.54],0.5424175951116327
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21970,61,1.36 [0.95-1.96],0.0961620216604473
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,345,1.02 [0.83-1.25],0.8435451997130283
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19968,57,0.87 [0.49-1.54],0.6258291192811798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22470,2559,0.95 [0.88-1.03],0.2177290953606368
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22359,56,0.84 [0.47-1.51],0.5530748858486432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,22426,123,0.85 [0.58-1.26],0.4194199334931504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23306,886,0.98 [0.86-1.12],0.798152850020121
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,22368,65,0.70 [0.38-1.28],0.2465760352617763
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21658,4386,0.94 [0.89-1.00],0.0688234862047504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22596,293,0.76 [0.58-1.00],0.0530146434697867
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,22692,272,0.98 [0.78-1.23],0.8402653156512901
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Emphysema,20139,228,1.09 [0.88-1.34],0.4385108254564236
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22017,197,1.25 [1.00-1.56],0.0484692684972171
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23284,1375,1.02 [0.92-1.13],0.6488646265817254
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,22051,231,1.24 [1.01-1.52],0.03949117072846
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Later onset COPD,22664,614,0.98 [0.84-1.15],0.837111475322922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23449,180,1.13 [0.87-1.46],0.350315140419045
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,22361,58,0.66 [0.34-1.27],0.2102824568972575
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23255,793,1.02 [0.89-1.16],0.8271987581447271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,23294,1479,1.04 [0.95-1.15],0.3919721701015392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22976,673,0.83 [0.70-0.98],0.0301398430168769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other pleural conditions,21849,34,0.76 [0.34-1.70],0.4992558693376057
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23381,293,1.22 [1.01-1.46],0.0374204946982865
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23379,1005,1.04 [0.93-1.17],0.4947475476318582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,22518,703,1.05 [0.91-1.21],0.4756262639408868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural plaque,21856,41,1.03 [0.58-1.85],0.909602137918842
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23076,1167,1.02 [0.92-1.14],0.675073289202784
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23424,155,1.06 [0.79-1.42],0.7120037984173468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumothorax,21901,86,0.82 [0.50-1.33],0.41189994677748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pollen allergy,23430,203,0.84 [0.62-1.14],0.2603043342838675
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pulmonary oedema,23142,54,1.30 [0.87-1.93],0.1973564135897602
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16618,44,0.81 [0.40-1.68],0.5788287546445392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23236,774,1.01 [0.88-1.16],0.8509268715608376
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22545,242,0.78 [0.58-1.05],0.0962503248286574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Viral pneumonia,22091,182,1.03 [0.78-1.37],0.8196447516728017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23116,145,1.05 [0.77-1.44],0.7377170895959748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11308,89,0.83 [0.52-1.34],0.4511917226451403
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16779,36,0.90 [0.45-1.80],0.7648695897530868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,23289,120,0.71 [0.46-1.10],0.1262439188222964
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute gastritis,17614,72,1.41 [1.04-1.93],0.0283961213668853
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,21502,140,1.02 [0.74-1.40],0.9164322407771268
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute peritonitis,22973,73,1.14 [0.76-1.69],0.5292956601624264
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22714,30,0.71 [0.29-1.75],0.4583753740659885
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Barrett oesophagus,17839,297,0.95 [0.75-1.20],0.6488447410444461
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21430,68,1.02 [0.65-1.62],0.9194011451194258
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23104,68,1.03 [0.65-1.63],0.9094598627327304
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,21515,153,1.03 [0.76-1.39],0.8535590927337813
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,22385,1023,0.95 [0.84-1.08],0.4533555730848468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,17831,289,1.16 [0.94-1.41],0.1635596236500797
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21395,33,1.36 [0.85-2.17],0.2041483131060954
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23388,63,1.28 [0.87-1.87],0.2095576382400494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,22144,128,1.54 [1.26-1.89],2.328690196241148e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Collagenous colitis,21838,95,0.87 [0.55-1.36],0.529842218599988
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23333,134,1.05 [0.77-1.44],0.7622883258486961
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,23166,1453,0.93 [0.83-1.03],0.1622030635745288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,21812,69,1.08 [0.71-1.66],0.7084921960937779
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23154,49,1.18 [0.74-1.87],0.4970277318835228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21816,73,1.07 [0.71-1.63],0.747663121673523
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,22750,202,1.14 [0.90-1.45],0.2739519067116174
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22058,2092,1.08 [1.00-1.17],0.056997057814313
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,23327,158,0.82 [0.58-1.16],0.2694830514425906
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,23372,688,0.97 [0.83-1.13],0.6676117590823168
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21490,3948,1.01 [0.95-1.07],0.7775742567521772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23060,512,1.10 [0.94-1.28],0.2312779824122545
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23350,450,1.17 [1.00-1.37],0.0447369318829971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22649,101,1.13 [0.80-1.58],0.4885185533393361
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22521,55,0.94 [0.54-1.62],0.8236542932556017
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23203,1187,1.12 [1.01-1.24],0.0264451647988341
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of tongue,22526,89,1.02 [0.69-1.51],0.9145694414853304
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22723,1361,0.99 [0.89-1.10],0.8745814814252411
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19480,2737,1.02 [0.95-1.09],0.6666304332551432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,17658,116,0.99 [0.68-1.44],0.9692542634523602
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23408,96,0.94 [0.61-1.43],0.7584838843094397
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23369,57,1.31 [0.92-1.88],0.1389851167256679
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22764,80,1.20 [0.83-1.72],0.3298187223104288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16841,98,0.94 [0.63-1.40],0.7671488605406512
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,18114,572,1.10 [0.94-1.27],0.2273762873589465
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,17839,297,1.18 [0.97-1.43],0.0907080430216559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19929,2387,0.93 [0.86-1.01],0.1045729220524098
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17951,409,1.13 [0.96-1.35],0.1507428941888807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18365,7206,1.02 [0.98-1.07],0.3545983429892567
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,22959,943,1.03 [0.92-1.17],0.5968110492511753
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22610,62,1.09 [0.69-1.71],0.7248696574266658
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17577,1084,1.07 [0.96-1.19],0.2306303841444652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22716,32,1.40 [0.86-2.27],0.1761332936743865
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,22432,2466,1.11 [1.04-1.20],0.0029899911629044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,23377,52,1.38 [0.96-1.96],0.0787604557562733
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impaction of intestines,16801,58,1.11 [0.71-1.74],0.6453953753572945
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,20115,149,1.50 [1.22-1.85],9.919123937360302e-05
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16829,86,1.04 [0.70-1.54],0.8626176785879456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22170,154,1.47 [1.21-1.79],0.0001242582753082
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17435,692,0.92 [0.79-1.07],0.2927681158680755
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23445,297,0.93 [0.73-1.18],0.5419616269170595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22447,704,1.11 [0.97-1.26],0.1233470775334631
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22683,940,1.04 [0.93-1.18],0.4915590517768591
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17674,132,0.97 [0.68-1.38],0.8678667132582742
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,18032,490,1.04 [0.88-1.24],0.6202465878054904
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23418,139,0.85 [0.59-1.23],0.3922256573044973
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20017,51,0.86 [0.46-1.62],0.6507809656302721
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17826,1083,1.06 [0.95-1.18],0.2749178685537705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21611,249,1.15 [0.93-1.42],0.2086760762741619
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21521,159,0.95 [0.69-1.30],0.741861474360835
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,18101,1358,1.08 [0.98-1.19],0.1103876248781342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,21606,4863,1.00 [0.95-1.06],0.8626059907125205
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22531,200,0.89 [0.66-1.20],0.4347709537649677
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,23258,574,0.98 [0.83-1.15],0.7734160723285416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18050,508,1.07 [0.91-1.26],0.4226466593993415
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21493,131,0.93 [0.65-1.33],0.6834785276335914
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23293,393,1.17 [0.99-1.38],0.0598498184081986
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18475,933,1.08 [0.95-1.21],0.2335868838878112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22975,959,1.03 [0.92-1.17],0.5859407982236337
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22700,152,1.15 [0.88-1.51],0.317602105946714
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18245,1502,0.94 [0.85-1.05],0.2639212918044419
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19334,1792,1.09 [1.00-1.18],0.0579200343598971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22772,88,1.36 [1.01-1.82],0.0413190047385913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22577,834,1.08 [0.95-1.22],0.2481840153899401
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17026,283,1.09 [0.88-1.34],0.4339442939310243
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23361,66,1.29 [0.91-1.82],0.1487159236729038
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17167,424,1.15 [0.98-1.35],0.0938218745000828
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22134,118,1.24 [0.94-1.65],0.1301450976831683
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23447,64,1.09 [0.71-1.69],0.6846801085238192
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22550,116,1.05 [0.75-1.47],0.7654655775698784
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Toxic colitis,21797,54,1.14 [0.71-1.83],0.585360148344964
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17749,207,0.92 [0.68-1.23],0.5587639204129324
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,21880,137,1.00 [0.72-1.39],0.9888132974584276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21856,113,1.12 [0.81-1.54],0.4873408521866934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,20113,147,1.14 [0.85-1.53],0.3929298610046652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16906,163,0.66 [0.45-0.99],0.0421872316479769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,20178,212,1.29 [1.05-1.59],0.0155819450852046
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Volvulus,16816,73,1.46 [1.10-1.94],0.0082749831220589
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23381,214,1.13 [0.89-1.42],0.3216579418465591
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23176,73,1.00 [0.64-1.55],0.9830967119918048
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21712,193,0.94 [0.70-1.25],0.6678632337782566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22992,540,1.10 [0.94-1.28],0.2315264881130648
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22580,128,1.28 [0.98-1.66],0.070148078567601
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21786,267,1.18 [0.97-1.44],0.1052099846697849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23183,243,0.96 [0.75-1.24],0.7613161791887353
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23357,417,1.07 [0.89-1.27],0.4733853797285228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22982,42,0.80 [0.40-1.60],0.5307287195434114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22078,2701,1.03 [0.96-1.11],0.3537645732702632
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23068,403,1.13 [0.95-1.33],0.1692185567262519
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22941,276,1.13 [0.92-1.39],0.2296239019161553
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23179,727,1.10 [0.97-1.25],0.1534807033489827
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23436,67,1.12 [0.73-1.70],0.6058540538597224
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21605,86,1.20 [0.85-1.70],0.2921895987016282
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22705,40,1.25 [0.77-2.01],0.3641740457814331
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23169,229,0.87 [0.65-1.15],0.3231420154036154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21875,356,0.97 [0.78-1.19],0.7545606448604043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21565,46,1.03 [0.59-1.79],0.9295348482067668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23369,68,1.33 [0.95-1.87],0.0967248471379247
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22581,129,1.03 [0.74-1.44],0.8526533402667971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23250,147,1.05 [0.77-1.42],0.7757978982603364
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22982,42,1.52 [1.03-2.22],0.0335143761108703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21573,54,0.78 [0.41-1.46],0.4360081764407779
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22870,1351,1.03 [0.93-1.14],0.5878400451910776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21906,387,0.93 [0.76-1.15],0.5035652343988791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21567,48,1.04 [0.61-1.78],0.8786671695810464
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23380,277,1.04 [0.83-1.30],0.7201201608152032
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23014,74,1.31 [0.94-1.84],0.1139008696987504
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23316,213,1.03 [0.80-1.33],0.816559755367263
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23407,240,1.11 [0.89-1.39],0.3651080866718919
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21660,141,0.80 [0.55-1.17],0.246755668024677
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21742,223,0.96 [0.73-1.25],0.7417677321264875
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23396,229,1.10 [0.87-1.39],0.4160488264304518
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21686,167,1.35 [1.08-1.68],0.0077133231807122
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23426,125,1.13 [0.83-1.53],0.4332327425133052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20014,112,0.87 [0.58-1.30],0.4925470377156715
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21302,5467,0.95 [0.90-1.00],0.0681173428962917
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20124,4289,0.94 [0.89-1.00],0.0597026360277599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19967,65,0.66 [0.35-1.23],0.1886051487592612
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20128,133,0.75 [0.50-1.13],0.1703654041622406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20177,182,1.05 [0.80-1.38],0.7345820748591434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23213,98,0.72 [0.44-1.18],0.1975217295662434
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20096,101,1.06 [0.73-1.54],0.7762064993309213
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17027,1192,0.88 [0.78-1.00],0.0500782570465605
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23319,198,0.76 [0.55-1.07],0.1141769514796179
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20496,501,0.96 [0.80-1.15],0.6231620287582273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19703,6946,0.98 [0.93-1.02],0.2979194181051959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21025,114,0.89 [0.60-1.33],0.5645209221776597
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20016,114,0.92 [0.62-1.35],0.6646287541737874
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20494,592,0.77 [0.64-0.93],0.0077322688662015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22575,2580,0.97 [0.89-1.04],0.3755591230149959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20057,155,1.05 [0.78-1.40],0.7583486808219284
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20236,334,1.01 [0.82-1.24],0.9390786903907066
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20051,149,0.76 [0.52-1.10],0.1478903668025654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22605,95,1.17 [0.83-1.64],0.3820858242411392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17458,1623,0.98 [0.88-1.08],0.6224560185483681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16015,180,1.15 [0.89-1.47],0.285120176625979
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23443,177,1.20 [0.93-1.54],0.1613897428050706
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15925,90,0.98 [0.65-1.46],0.9170182372537384
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16329,494,0.78 [0.63-0.95],0.0164257462512287
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20192,290,0.96 [0.76-1.21],0.7216350270645503
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16388,553,0.91 [0.77-1.09],0.315619816016003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20053,58,0.83 [0.45-1.50],0.5299579576414588
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20612,617,0.92 [0.78-1.09],0.3422012334719189
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20284,289,0.86 [0.67-1.11],0.2393560203440599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16349,514,0.89 [0.74-1.07],0.2232572146365902
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19975,73,1.02 [0.66-1.58],0.938416006077422
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19962,60,0.86 [0.49-1.50],0.5848767400672559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20953,42,0.98 [0.53-1.79],0.9383499424781876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23051,2140,1.04 [0.96-1.13],0.3646402304771031
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22456,1545,1.08 [0.99-1.18],0.0977368262477264
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23274,503,0.93 [0.77-1.11],0.4091242212647211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18447,2612,0.94 [0.87-1.02],0.1294295659327312
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15896,61,0.78 [0.43-1.40],0.4067364067273344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19991,89,0.80 [0.49-1.30],0.3649252454988061
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15877,42,0.59 [0.26-1.34],0.2051605456360664
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16009,174,1.18 [0.92-1.50],0.1858363741219838
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21163,252,0.93 [0.71-1.20],0.5589556546578991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21394,483,1.05 [0.89-1.24],0.5833341188646457
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23431,93,0.96 [0.64-1.45],0.8583254599668656
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21745,1750,0.95 [0.87-1.05],0.3469528396450991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20014,112,1.01 [0.71-1.44],0.9439263160466934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16034,199,0.76 [0.55-1.06],0.1093692195353097
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20696,701,0.91 [0.78-1.07],0.2564738616511937
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18023,2188,0.90 [0.82-0.98],0.0187024858174044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22625,115,1.34 [1.03-1.74],0.0294371625994652
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23437,72,0.99 [0.64-1.55],0.982329293949938
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19967,65,1.02 [0.63-1.63],0.940812044805566
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21168,1266,1.03 [0.93-1.15],0.5606880973185182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19970,68,0.91 [0.55-1.51],0.7267642341822611
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17541,1706,0.91 [0.82-1.00],0.0604136601109501
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21034,123,0.77 [0.50-1.18],0.2280285752998951
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19951,49,0.47 [0.21-1.06],0.0691785878425787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20164,169,1.21 [0.95-1.55],0.1287179982180641
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20392,490,1.13 [0.97-1.32],0.1196473565613456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22955,445,1.11 [0.94-1.31],0.2346591808079012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20551,556,1.00 [0.85-1.18],0.9860663733787248
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23286,486,0.92 [0.76-1.11],0.4038959405680603
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23433,58,0.84 [0.47-1.50],0.5615218625417626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20096,194,0.78 [0.56-1.08],0.1311314078657401
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17957,782,0.88 [0.75-1.02],0.094641714558745
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20472,570,0.98 [0.84-1.16],0.8485228210199456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20008,106,1.11 [0.80-1.55],0.524271048990578
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15906,71,1.18 [0.81-1.73],0.3845491861589444
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18097,2262,0.92 [0.85-1.01],0.0763662776321511
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16557,722,0.79 [0.67-0.94],0.0066102722002125
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22764,254,1.05 [0.83-1.33],0.6791290924612119
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23405,67,1.04 [0.66-1.64],0.8553545303092311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21480,47,0.79 [0.39-1.58],0.5023373421472108
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15908,73,0.98 [0.63-1.53],0.9396310897357016
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20089,94,0.87 [0.55-1.36],0.5297017263376405
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16342,507,0.92 [0.77-1.11],0.3769642577667143
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20179,277,0.72 [0.54-0.97],0.0298616719295708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20242,247,1.03 [0.82-1.31],0.7792738098158565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20233,238,0.91 [0.69-1.20],0.505283988144164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18074,75,0.67 [0.38-1.20],0.1799196127540097
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23438,63,0.78 [0.44-1.40],0.4127649568788559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20448,546,0.92 [0.77-1.10],0.3455402739217894
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22655,145,1.27 [0.99-1.63],0.0579384940795703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22323,2421,0.98 [0.90-1.06],0.5475062272634693
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20036,134,1.25 [0.95-1.63],0.1048658509622664
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20478,483,1.12 [0.96-1.31],0.1642707462270412
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21955,218,1.14 [0.90-1.44],0.276853954324971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20208,213,1.07 [0.83-1.37],0.6229579738807354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21480,1485,0.97 [0.88-1.08],0.6235521770390768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21006,1011,0.93 [0.81-1.06],0.2488487513131086
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19957,55,0.90 [0.51-1.60],0.7219375416837162
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22716,206,1.20 [0.96-1.51],0.1023357603724987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20073,171,0.81 [0.58-1.14],0.2290431135787637
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20016,114,1.32 [1.00-1.73],0.0463113079804576
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15877,42,1.05 [0.59-1.85],0.8670691374733533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22627,1026,1.13 [1.01-1.26],0.0288153160840136
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,0.99 [0.66-1.48],0.9596220986264398
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,1.16 [0.83-1.61],0.3910414771483294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23323,199,0.92 [0.69-1.23],0.5827330654267999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23147,23,0.84 [0.34-2.10],0.7161564136061467
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22745,1144,1.21 [1.10-1.34],0.0001287788762323
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23316,58,1.12 [0.70-1.79],0.6498189610521896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23290,198,0.96 [0.72-1.28],0.7653613800074864
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,20714,213,1.17 [0.93-1.47],0.1749594358511452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dialysis,21646,45,1.56 [1.08-2.25],0.0177037283557866
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,1.14 [0.93-1.39],0.2017050067739423
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,1.01 [0.75-1.36],0.9249054347098102
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,0.92 [0.75-1.14],0.4407752798355058
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,0.98 [0.86-1.12],0.7638617413537759
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18201,4230,1.04 [0.98-1.10],0.2280295009096897
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23309,51,1.53 [1.10-2.14],0.0122863196534653
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21486,176,0.71 [0.49-1.04],0.0756069059303928
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,0.98 [0.79-1.21],0.825873948040286
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.82 [0.54-1.24],0.3500827274397852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,0.96 [0.76-1.20],0.6913779664797626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20568,67,0.79 [0.45-1.38],0.4096680606014966
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,1.01 [0.93-1.10],0.747113085300492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,1.08 [0.79-1.48],0.625569387009322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23446,56,1.12 [0.71-1.78],0.6195158288354352
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23446,65,1.37 [0.98-1.92],0.0665597593334161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22381,1880,1.01 [0.92-1.10],0.846140158161372
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20907,406,1.17 [0.99-1.38],0.063198707998232
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,1.15 [0.82-1.60],0.4262923659014772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23407,315,1.06 [0.86-1.30],0.5967773622465391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23405,76,1.07 [0.71-1.61],0.7553928883056715
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22106,1605,1.00 [0.91-1.10],0.949957114502969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.01 [0.76-1.34],0.9659417216534808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,0.82 [0.56-1.20],0.3034363663453474
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,0.84 [0.66-1.07],0.1563902165756968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,1.24 [0.92-1.68],0.1589587496080449
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,0.78 [0.55-1.11],0.1718342924827839
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21529,219,0.86 [0.64-1.16],0.3156017107892734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23194,102,0.99 [0.68-1.46],0.97255628660827
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.18 [0.97-1.43],0.093890519520028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,0.97 [0.66-1.44],0.896234550960342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,1.08 [0.94-1.26],0.2831920980307754
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,0.94 [0.67-1.33],0.7254834984214107
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,1.09 [0.94-1.27],0.259075863511682
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23292,34,0.97 [0.50-1.89],0.9347011927740614
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23308,1998,1.14 [1.05-1.23],0.0013362222169747
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21453,143,1.10 [0.82-1.48],0.5042025780008557
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21678,77,1.10 [0.72-1.67],0.6604920396617417
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,0.80 [0.35-1.80],0.5832839997741941
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20627,126,1.25 [0.95-1.64],0.1043424980478231
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23353,229,0.90 [0.68-1.19],0.4575455649862389
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,1.03 [0.74-1.43],0.8826073254962623
